| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6107670 | Journal of Hepatology | 2008 | 7 Pages |
Abstract
The combination of telaprevir, peginterferon alfa-2a, and ribavirin was generally well tolerated. Events of pruritus and rash resolved during or after end of telaprevir dosing. All 12 patients achieved an RVR.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Eric Lawitz, Maribel Rodriguez-Torres, Andrew J. Muir, Tara L. Kieffer, Lindsay McNair, Ariya Khunvichai, John G. McHutchison,